HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the sale, the insider now owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Stephen Neeleman also recently made the following trade(s):
- On Friday, June 7th, Stephen Neeleman sold 2,080 shares of HealthEquity stock. The stock was sold at an average price of $85.01, for a total value of $176,820.80.
- On Tuesday, June 4th, Stephen Neeleman sold 400 shares of HealthEquity stock. The stock was sold at an average price of $85.00, for a total value of $34,000.00.
HealthEquity Stock Up 0.1 %
HQY stock opened at $78.48 on Thursday. HealthEquity, Inc. has a twelve month low of $61.81 and a twelve month high of $88.26. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44. The firm has a market cap of $6.83 billion, a PE ratio of 85.30, a price-to-earnings-growth ratio of 1.34 and a beta of 0.57. The business has a 50 day moving average of $81.44 and a 200 day moving average of $80.14.
Wall Street Analysts Forecast Growth
HQY has been the subject of several research analyst reports. KeyCorp increased their price objective on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. Wells Fargo & Company increased their target price on HealthEquity from $107.00 to $110.00 and gave the stock an “overweight” rating in a research report on Thursday, June 20th. Raymond James increased their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Friday, June 7th. Robert W. Baird increased their target price on HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 4th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 target price on shares of HealthEquity in a research report on Tuesday, June 4th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $101.67.
Get Our Latest Report on HealthEquity
Institutional Trading of HealthEquity
A number of institutional investors and hedge funds have recently modified their holdings of HQY. Cape Investment Advisory Inc. bought a new stake in shares of HealthEquity in the 4th quarter worth $27,000. Rise Advisors LLC bought a new stake in shares of HealthEquity in the 1st quarter worth $28,000. McGlone Suttner Wealth Management Inc. bought a new stake in shares of HealthEquity in the 4th quarter worth $29,000. International Assets Investment Management LLC purchased a new position in shares of HealthEquity in the 2nd quarter worth $35,000. Finally, YHB Investment Advisors Inc. purchased a new position in shares of HealthEquity in the 1st quarter worth $40,000. Institutional investors own 99.55% of the company’s stock.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
- Five stocks we like better than HealthEquity
- With Risk Tolerance, One Size Does Not Fit All
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- EV Stocks and How to Profit from Them
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.